Lucid Diagnostics Stock Quote LUCD - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.8398

Bid

0.8003

Ask

0.90

Volume

105,971

0.83 Day's Range 0.88

0.6301 52 Week Range 1.73

Market Cap

43.776M

Previous Close

0.84

Open

0.85

Last Trade

0.8648

Last Trade Time

Financial Volume

$ 89,717

VWAP

0.846622

Average Volume (3m)

184,622

Shares Outstanding

52,114,353

Dividend Yield

PE Ratio

-0.83

Earnings Per Share (EPS)

-1.01

Revenue

2.43M

Net Profit

-52.67M

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Headquarters

Wilmington, Delaware, USA

Founded

1970

Lucid Diagnostics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUCD. The last closing price for Lucid Diagnostics was $0.84. Over the last year, Lucid Diagnostics shares have traded in a share price range of $ 0.6301 to $ 1.73.

Lucid Diagnostics currently has 52,114,353 shares outstanding. The market capitalization of Lucid Diagnostics is $43.78 million. Lucid Diagnostics has a price to earnings ratio (PE ratio) of -0.83.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Lucid Diagnostics Launches New Corporate Website

Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK, July 11, 2024 NEW YORK, July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a...

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0302	-3.47126436782	0.87	0.9024	0.83	116625	0.8701995	CS
4	0.1463	21.095890411	0.6935	0.92	0.681	178033	0.8077438	CS
12	0.1621	23.9191382618	0.6777	1.11	0.664	184622	0.86498905	CS
26	-0.6602	-44.0133333333	1.5	1.58	0.6301	172746	0.95530273	CS
52	-0.5602	-40.0142857143	1.4	1.73	0.6301	106514	1.03889962	CS
156	-11.9102	-93.4133333333	12.75	13.5	0.6301	125080	3.29977454	CS
260	-11.9102	-93.4133333333	12.75	13.5	0.6301	125080	3.29977454	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SERVServe Robotics Inc	$ 7.51 (185.55%)	266.26M
AUGXAugmedix Inc	$ 2.27 (147.71%)	24.14M
XCURExicure Inc	$ 0.5351 (76.02%)	14.02M
PSNLPersonalis Inc	$ 3.83 (56.33%)	22.8M
MDBHMDB Capital Holdings LLC	$ 10.675 (37.21%)	126.45k
SPWRSunPower Corporation	$ 0.6735 (-55.40%)	124.61M
HYZNHyzon Motors Inc	$ 0.149 (-47.54%)	23.63M
MEDSTRxADE Health Inc	$ 14.92 (-33.45%)	223.27k
SILOSilo Pharma Inc	$ 2.50 (-27.95%)	11.93M
KITTNauticus Robotics Inc	$ 0.0935 (-27.46%)	28.43M
SERVServe Robotics Inc	$ 7.51 (185.55%)	262.73M
NVDANVIDIA Corporation	$ 117.93 (-2.61%)	206.41M
SXTP60 Degrees Pharmaceuticals Inc	$ 0.2602 (5.77%)	202.14M
SQQQProShares UltraPro Short QQQ	$ 8.46 (2.79%)	184.21M
SPWRSunPower Corporation	$ 0.6735 (-55.40%)	119.98M